OncoMatch/Clinical Trials/Testicular / Germ Cell Cancer
Testicular / Germ Cell Cancer Clinical Trials
OncoMatch filters Testicular / Germ Cell Cancer trials by the molecular markers that determine eligibility — KIT, KRAS, and more. Enter your biomarker results to see only the trials you may qualify for.
Compare eligibility criteriaTop recruiting Testicular / Germ Cell Cancer trials
Ranked by phase and number of US sites. See all trials matched to your profile →
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Children's Oncology Group
Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.
Indiana University
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
University of Sydney
Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors
Gustave Roussy, Cancer Campus, Grand Paris
TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors
Beihua Kong
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Children's Oncology Group
How OncoMatch finds Testicular / Germ Cell Cancer trials for you
AI reads the protocol
Every Testicular / Germ Cell Cancer trial on ClinicalTrials.gov has eligibility criteria written for regulators. OncoMatch uses large language models to extract the structured requirements — biomarkers, stage, prior therapy, and more — from that text.
You enter your results
Select Testicular / Germ Cell Cancer and mark your biomarker results — KIT, KRAS — as positive, negative, or not tested. Your data never leaves your device.
See only relevant trials
Results filter instantly. Each trial shows exactly which criteria you meet, which you don't, and which need more information. Bring the list to your oncologist.